Loss of prolyl hydroxylase‐2 in myeloid cells and T‐lymphocytes impairs tumor development
Open Access
- 3 August 2013
- journal article
- research article
- Published by Wiley in International Journal of Cancer
- Vol. 134 (4) , 849-858
Abstract
The tumor microenvironment plays a pivotal role during cancer development and progression. The balance between suppressive and cytotoxic responses of the tumor immune microenvironment has been shown to have a direct effect on the final outcome in various human and experimental tumors. Recently, we demonstrated that the oxygen sensor HIF-prolyl hydroxylase-2 (PHD2) plays a detrimental role in tumor cells, stimulating systemic growth and metastasis in mice. In our current study, we show that the conditional ablation of PHD2 in the hematopoietic system also leads to reduced tumor volume, intriguingly generated by an imbalance between enhanced cell death and improved proliferation of tumor cells. This effect seems to rely on the overall downregulation of protumoral as well as antitumoral cytokines. Using different genetic approaches, we were able to confine this complex phenotype to the crosstalk of PHD2-deficient myeloid cells and T-lymphocytes. Taken together, our findings reveal a multifaceted role for PHD2 in several hematopoietic lineages during tumor development and might have important implications for the development of tumor therapies in the future.Keywords
Funding Information
- Emmy Noether Program (the Deutsche Forschungsgemeinschaft-DFG, Germany), MeDDrive-Programm (TU Dresden, Germany)
- DFG, Germany (WI 3291/1-1, 1-2 and SPP 1190 “The Tumor-Vessel Interface”.)
This publication has 45 references indexed in Scilit:
- Hallmarks of Cancer: The Next GenerationCell, 2011
- Intratumor T helper type 2 cell infiltrate correlates with cancer-associated fibroblast thymic stromal lymphopoietin production and reduced survival in pancreatic cancerJournal of Experimental Medicine, 2011
- Interactions between lymphocytes and myeloid cells regulate pro- versus anti-tumor immunityCancer and Metastasis Reviews, 2010
- Prolyl Hydroxylase EGLN3 Regulates Skeletal Myoblast Differentiation through an NF-κB-dependent PathwayJournal of Biological Chemistry, 2010
- Immunity, Inflammation, and CancerCell, 2010
- CD4+ T Cells Regulate Pulmonary Metastasis of Mammary Carcinomas by Enhancing Protumor Properties of MacrophagesCancer Cell, 2009
- Tumor Vasculature Is Regulated by PHD2-Mediated Angiogenesis and Bone Marrow-Derived Cell RecruitmentCancer Cell, 2009
- Oxygen Sensing by Metazoans: The Central Role of the HIF Hydroxylase PathwayMolecular Cell, 2008
- Prolyl hydroxylase-1 negatively regulates IκB kinase-β, giving insight into hypoxia-induced NFκB activityProceedings of the National Academy of Sciences, 2006
- Tumour-educated macrophages promote tumour progression and metastasisNature Reviews Cancer, 2004